Article Publish Status: FREE
Abstract Title:

Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy.

Abstract Source:

J Physiol. 2009 Jan 15 ;587(Pt 1):219-30. Epub 2008 Nov 10. PMID: 19001041

Abstract Author(s):

Joanne E Mallinson, Dumitru Constantin-Teodosiu, James Sidaway, F Russell Westwood, Paul L Greenhaff

Article Affiliation:

Joanne E Mallinson


Statins are used clinically for cholesterol reduction, but statin therapy is associated with myopathic changes through a poorly defined mechanism. We used an in vivo model of statin myopathy to determine whether statins up-regulate genes associated with proteasomal- and lysosomal-mediated proteolysis and whether PDK gene expression is simultaneously up-regulated leading to the impairment of muscle carbohydrate oxidation. Animals were dosed daily with 80 mg kg(-1) day(-1) simvastatin for 4 (n = 6) and 12 days (n = 5), 88 mg kg(-1) day(-1) simvastatin for 12 days (n = 4), or vehicle (0.5% w/v hydroxypropyl-methylcellulose and 0.1% w/v polysorbate 80; Control, n = 6) for 12 days by oral gavage. We found, in biceps femoris muscle, decreased Akt(Ser473), FOXO1(Ser253) and FOXO3a(Ser253) phosphorylation in the cytosol (P<0.05, P<0.05, P<0.001, respectively) and decreased phosphorylation of FOXO1 in the nucleus after 12 days simvastatin when compared to Control (P<0.05). This was paralleled by a marked increase in the transcription of downstream targets of FOXO, i.e. MAFbx (P<0.001), MuRF-1 (P<0.001), cathepsin-L (P<0.05), PDK2 (P<0.05) and PDK4 (P<0.05). These changes were accompanied by increased PPARalpha (P<0.05), TNFalpha (P<0.01), IL6 (P<0.01), Mt1A (P<0.01) mRNA and increased muscle glycogen (P<0.05) compared to Control. RhoA activity decreased after 4 days simvastatin (P<0.05); however, activity was no different from Control after 12 days. Simvastatin down-regulated PI3k/Akt signalling, independently of RhoA, and up-regulated FOXO transcription factors and downstream gene targets known to be implicated in proteasomal- and lysosomal-mediated muscle proteolysis, carbohydrate oxidation, oxidative stress and inflammation in an in vivo model of statin-induced myopathy. These changes occurred in the main before evidence of extensive myopathy or a decline in the muscle protein to DNA ratio.

Print Options

Sayer Ji
Founder of

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022, Journal Articles copyright of original owners, MeSH copyright NLM.